ProPhase Labs announced the launch of its newly redesigned corporate website showcasing the company’s diverse portfolio of subsidiaries and offerings, which include Nebula Genomics, ProPhase Diagnostics, ProPhase BioPharma, Pharmaloz Manufacturing, Inc., and TK Supplements.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRPH:
- ProPhase Labs Announces Launch of Redesigned Corporate Website
- ProPhase Labs making progress on multiple fronts, says H.C. Wainwright
- ProPhase Labs reports 2022 EPS $1.02 vs. 40c last year
- ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
- Prophase Labs (PRPH) Q4 Earnings Cheat Sheet
